XPLORE

Especialitat

Retina i Vitri

Títol complet

A Phase III Double-Blind, Parallel Group, Multicenter Study to Compare the Efficacy and Safety of Xlucane versus Lucentis in Patients with Neovascular Age-Related Macular Degeneration

Promotor

Xbrane Biopharma

Data d'inici

Juny 2019

Investigadors

Principal: Dra Anniken Burés

Co-Investigadors: Dr. Rafael Navarro, Dr. Borja Corcóstegui, Dr. Carlos Mateo, Dra. Cecilia Salinas